People · Operator
Named in public records as an officer, director or promoter · active 2010–2022 · Pharmaceuticals, Other Technology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Turing Pharmaceuticals AG | — | Pharmaceuticals | Series C | $153.0M | $3.2B | 2015 |
| Quantumid Technologies Inc | — | Other Technology | Seed | $3.2M | $85.2M | 2010 |
| Pyros Pharmaceuticals, Inc. | — | Biotech / Pharma | Pre-Seed | $880K | $8.1M | 2022 |
Ron Tilles at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ron Tilles on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Smith | 1 | 20 |
| Michael Harrison | 1 | 8 |
| Martin Shkreli | 1 | 3 |
| Edwin Urrutia | 1 | 1 |
| Christopher Cheever | 1 | 1 |
| Alan Geller | 1 | 1 |
| Walter Blum | 1 | 1 |
| Howard Dorfman | 1 | 1 |
| Milind Tavshikar | 1 | 1 |
| Prasanna Gogwekar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.